The Renewable Energy Centre Supports go ahead for new Tidal Projects
The Renewable Energy Centre announced its support of the projects and stated it was a positive step forward for tidal power industry in the light of recent focus by the government, on nuclear power.
The company behind SeaGen; Marine Current Turbines has been leading innovation in harnessing tidal power in the UK for many years and has received funding from both the government and nPower in order to reach this latest deployment. If the technology proves successful, a farm of seven SeaGen turbines will be installed off the coast of Anglesey in order to begin to tap into one of the most predictable forms of renewable energy available. Tidal power around the UK could provide from 10 to 20 percent of the UK’s energy needs over the next decade which would significantly help to reduce the impact of carbon emissions and serve to help the government meet EU energy targets.
The Renewable Energy Centre said that projects such as these should be at the heart of the government’s strategy to meet its energy targets. Marine power technology is cheaper and much quicker to install than other larger projects such as nuclear power or the much maligned Severn Barrage. Martin Wright, Managing Director at Marine Current Turbines said “SeaGen is a hugely exciting project as well as an historic achievement… Tidal energy has the great advantage of being predictable and no other system can harness the power of the tidal currents in the way this one can. We take great pride and see enormous potential in the technology and hope it will eventually make a significant contribution to the future energy needs of the British Isles, Ireland and beyond.”
SeaGen works below the surface of the sea and has two 16m diameter rotors which will operate 18-20 hours per day. The rotation of the blades each drives a generator via a gear box and convey the energy to the national grid. One of the unique aspects of the technology is that the blades can be repositioned to capture both the ebb and flow of the tide therefore maximising the energy potential.
John Hutton also expressed how significant the project is for the future of the UK’s energy targets saying “It is this sort of project which will help the UK meet our ambitious targets to increase the amount of energy from renewable sources.” Despite this, The Renewable Energy Centre said Hutton still needed to press further forward in terms of research and investment in order to proactively establish tidal power as leading industry.
Hutton also announced yesterday the approval for a prototype Pulse Generator to be installed in the Humber estuary. Developed by Pulse Generation Ltd the product boasts 90% efficiency in mechanical transmission enabling the system to turn at a higher frequency. The Pulse Generator is also ideal for harnessing shallower tidal currents which means the systems will be closer to shore, easier to install and maintain and therefore more cost effective. The estimated energy supply from the prototype to the national grid will, it is estimated, provide electricity for about 70 homes but if installed commercially it could supply over 70,000 homes in the UK.
The Renewable Energy Centre stated that both of these projects were positive for the renewable energy sector and when proven could, within a short space of time, be operational at a commercial level. Richard Simmons, Managing Director at The Renewable Energy Centre said “It is about time we heard that the government is taking tidal power seriously and that it is making the news. I believe tidal power is one of the best untapped sources of renewable energy the UK has to offer and to ignore its full potential is foolish and short sighted. There is still a tremendous need for the government to invest further in both our grid infrastructure and research and development of the technology. The UK has the potential to be a global leader in this arena but the government has to provide support to the industry to achieve this.
The Renewable Energy Centre concluded by saying that tidal power technology although still in its infancy was now moving towards commercial independence and that projects such as SeaGen and the Pulse Generator would prove valid sources of clean, predictable renewable energy for the future.
For more information:
Contact: Angela Gallacher (Head of Press & Marketing)
Address: 1 Alpha House, Farmer Ward Road, Kenilworth, Warwickshire, CV8 2ED
Telephone: 01926 865835
Notes for Editors
The Renewable Energy Centre: Saving Money, Saving Energy and Saving the Planet
The Renewable Energy Centre is committed to informing all online users about energy saving and renewable energy in order to:
• increase public awareness through accurate and informative resources
• create business opportunities throughout the UK through its’ local and
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Renewable Energy Centre Supports go ahead for new Tidal Projects here
News-ID: 41635 • Views: …
More Releases from The Renewable Energy Centre
The Renewable Energy Centre supports Wind Power on the BBC Politics Show.
Managing Director, Richard Simmons put forward his arguments highlighting the benefits of wind power live on The Politics Show on Sunday, in response to a proximity bill being introduced by MP Peter Luff to the House of Commons today. The Politics Show regional section for the West Midlands was covering the debate about a proposed wind farm site in Lenchwick, Worcestershire. The local MP Peter Luff is today proposing a
2009 Budget: It was good but not good enough
The Renewable Energy Centre yesterday commented that Alistair Darlings 2009 budget took a small step in the right direction towards developing the renewables industry to ensure a firm and stable future for the UK. With figures amounting to over a billion pounds which would be allocated to reducing carbon emissions and expanding the UK’s renewables portfolio the 2009 budget seemed a positive step forward. Certainly the wind industry, which is
Further reductions of Carbon Emissions required by 2020
A report issued by the Tyndall Centre of Climate Change this week highlighted that predictions about climate change and the reduction of carbon dioxide emissions may have been too optimistic. The Renewable Energy Centre issued a statement in support of the recommendation that the UK should increase its 2020 target from 34% to a 42% reduction. The Centre has always supported the view that not enough action has been taken
The Renewable Energy Centre warns against runway three at Heathrow
Transport Secretary, Jeff Hoon announced today that an additional runway and terminal at Heathrow could go ahead. The Renewable Energy Centre released a statement warning that the consequences of such a move could be catastrophic. Although not predicted to be in operation until 2020, the new runway will herald a significant shift in the amount of carbon and other damaging gases that the UK will emit into the atmosphere. It
More Releases for SeaGen
Adult T-Cell Leukemia Market, Epidemiology, Pipeline Therapies, Drugs, Companies …
DelveInsight's "Adult T-Cell Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Adult T-Cell Leukemia-Lymphoma, historical and forecasted epidemiology as well as the Adult T-Cell Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Adult T-Cell Leukemia market report provides current treatment practices, emerging drugs, Adult T-Cell Leukemia market share of the individual therapies, current and forecasted Adult
Oncology Antibody Drug Conjugates Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027. Pfizer Inc., Astellas Pharma Inc., Gilead Sciences, Inc., GlaxoSmithKline, F. Hoffmann-La Roche AG, Daiichi Sankyo, AstraZeneca, Sanofi, AbbVie, Merck & Co., Byondis, RemeGen, ImmunoGen, Seagen, Rakuten Medical,
Antibody-drug Conjugate for Cancer Market 2022-2027 Exhibit A Huge Growth By Pro …
Global Antibody-drug Conjugate for Cancer Market Report 2022 – 2027 is a reliable source for market research that will help you grow your business enormously. SWOT and Porter's five analyses are also explained in depth to assess data such as cost, prices, revenue, and end-users. The report begins with a review of the industry, including definitions, applications, and technologies, before moving on to the international players in the market. The
Pharmaceutical Drug Development Sector Market Set for Explosive Growth | Catalen …
The “ Pharmaceutical Drug Development Sector Scorecard, Q3 2021 - Market Development Scenario ” Study has been added to HTF MI database. The study covers in-depth overview, description about the Product, Industry Scope and elaborates market outlook and growth status to 2027. At present, the market is developing its presence following current economic slowdown and its Impact. Some of the key players considered in the study are Takeda Pharmaceutical Co
RAS Targeting Therapies Market Inclining Revenues by 2021-2028| Amgen, F. Hoffma …
RAS, a small GTPase, is one of the most frequently altered proteins in cancer. Decades of research into the mechanisms through which RAS is activated and affects downstream signalling have elucidated much of the basic biology that underpins this key molecule. Clinical guidelines for RAS mutant (MT) MSS mCRC recommend chemotherapy (FOLFOX or FOLFIRI or FOLFOXIRI) with the addition of anti-vascular endothelial growth factor agents (bevacizumab in first line, bevacizumab or
PD-1 Resistant Head and Neck Cancer (HNC) Market Insight, Epidemiology and Marke …
PD-1 Resistant Head and Neck Cancer (HNC) Market research report is the new statistical data source added by Infinity Business Insights. Squamous cell carcinoma of the hypopharynx, oropharynx, lip, oral cavity, nasopharynx, and larynx is a heterogeneous illness covering numerous malignancies that start in the hypopharynx, oropharynx, lip, oral cavity, nasopharynx, or larynx. The disease category as a whole has a variety of epidemiology, aetiology, and treatment options. It is